In NASH, PLIN5 has been suggested to respond to hepatosteatosis by regulating triglyceride metabolism, lipid storage, lipolysis and mitochondrial proliferation [7,8,9]. The gene discussed is PLIN5; the disease is metabolic dysfunction-associated steatohepatitis.